-
1
Результаты проведения фармакоэкономических анализов при лечении болезни Паркинсона агонистом дофаминовых рецепторов Мирапексом...
Published 2018-06-01Subjects: Get full text
Article -
2
-
3
Pharmacoeconomic analysis of adjuvant use of zonisamide therapy resistant partial epilepsy in adults
Published 2018-06-01Subjects: Get full text
Article -
4
Фармакоэкономический анализ применения противопаркинсонических препаратов в режиме монотерапии на ранних стадиях болезни Паркинсона...
Published 2018-06-01Subjects: “…анализ эффективности затрат, анализ полезности затрат…”
Get full text
Article -
5
Pharmacoeconomic analysis of alogliptin use in the treatment of type 2 diabetes
Published 2018-05-01Subjects: Get full text
Article -
6
Pharmacoeconomics of dapagliflozin in patients with type 2 diabetes mellitus with inadequate glycemic control
Published 2018-06-01Subjects: Get full text
Article -
7
Pharmacoeconomic analysis of perampanel for resistance partial epilepsy
Published 2018-06-01Subjects: Get full text
Article -
8
-
9
Pharmacoeconomic analysis of naft idrofuryl in patients with chronic obliterating diseases of lower limb arteries
Published 2018-05-01Subjects: Get full text
Article -
10
Pharmacoeconomic analysis of flexible-dose administration regimen of Xeomine® in patients with focal dystonia
Published 2018-06-01Subjects: Get full text
Article -
11
Assessment of the economic efficiency of the anesthetic nefopam in therapy postoperative pain
Published 2018-06-01Subjects: Get full text
Article -
12
Pharmacoeconomic evaluation of pramipexole extended release monotherapy in early Parkinson’s disease
Published 2018-05-01Subjects: Get full text
Article -
13
Pharmacoeconomic analysis of Cocarnit® complex as treatment for diabetic polyneuropathy
Published 2018-05-01Subjects: Get full text
Article -
14
Pharmacoeconomic analysis of anti-VEGF therapy for age-related macular degeneration
Published 2018-05-01Subjects: Get full text
Article